Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
ASD
33
HOLDINGS
21%
ALSO IN XPH
XPH
57
HOLDINGS
12%
ALSO IN ASD
SECTOR DRIFT (ASD minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ASD |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 3.3% | 2.5% | 2.5% |
|
PFIZER INC | 2.8% | 2.2% | 2.2% |
|
JOHNSON & JOHNSON | 2.7% | 2.0% | 2.0% |
|
SUPERNUS PHARMACEUTICALS INC | 2.6% | 2.0% | 2.0% |
|
BRISTOL-MYERS SQUIBB CO | 2.5% | 1.9% | 1.9% |
ASD Overweight Relative to XPH
|
PERKINELMER INC | 3.3% |
 |
DAINIPPON SUMITOMO PHARMA CO | 3.1% |
 |
NOVARTIS AG | 3.0% |
|
TAKEDA PHARMACEUTICAL CO LTD | 3.0% |
 |
MEDICOVER AB - B SHARE | 3.0% |
 |
TEVA PHARMACEUTICAL IND LTD | 3.0% |
|
ABBVIE INC | 3.0% |
|
BRIGHTSPRING HEALTH SERVICES, INC. | 3.0% |
 |
PEARSON PLC | 2.9% |
|
REPLIGEN CORP | 2.8% |
ASD Underweight Relative to XPH
|
VERADERMICS INC | -2.8% |
|
PACIRA PHARMACEUTICALS INC | -2.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.5% |
|
VIATRIS, INC. | -2.3% |
|
MAZE THERAPEUTICS INC | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
 |
PERRIGO CO | -2.2% |
|
ZOETIS INC | -2.2% |
|
SEPTERNA INC | -2.2% |